Search results for query: sensorion

In this (https://globenewswire.com/news-release/2018/04/23/1485108/0/en/Sensorion-s-SENS-401-Reduces-Hearing-Loss-in-Preclinical-Study-When-Oral-Administration-Initiated-Up-to-Four-Days-after-Acoustic-Trauma.html) ridiculously hyped press release we learn a bit of interesting information. (In...

...the Society for Neuroscience (SfN), Neuroscience 2016, which will be held on November 12 - 16 , 2016 in San Di e go, California." or "Sensorion has decided to select SENS - 401 , instead of 218 , as its final drug candidate for treating lesions of the inner ear" > "lesions of...

...antagonist Otonomy - OTO-313 Auris Medical - AM-111 (keyzilen; for acute tinnitus) Potassium channel opener Xenon Pharma - XEN-1101a (new retigabine, for epilepsy) Autifony - Kv3.1 For SSNHL (acute) Sensorion - SENS-401 Devices University of Michigan (signal timing) Mute Button And more!

i wonder if it would work more on... protecting the ear from damage on meniers attack...and stop them. Or.. more like "okey you have tinnitus and hearing loss but you can take this pill and go everywhere you want, because it would protect you from further damage"

http://www.sensorion-pharma.com/images/press-release/20181221-PR-SENS401-OtoNeuroJournal.pdf The Sensorion pre-clinical team tested the efficacy of SENS-401 against severe acoustic trauma-induced hearing loss in a male rat model using auditory brainstem response (ABR), distortion product...

Agreed Its a classic pump and dump. Shareholders probably paid for this press release and have their fingers on the trigger, but the market does not seem to be fooled.

There is also a "kinda" new hearing aids out that supposedly can help with tonal tinnitus. It has built in notch therapy. I'd like to try it now but they are kind of expensive. :( https://pro.signiausa.com/tinnitus/signia-notch-therapy/

http://www.businesswire.com/news/home/20160222005808/en/Sensorion-Presents-SENS-218-Data-Association-Research-Otolaryngology This drug is too late for most of us. What I do like is that they are able to get the molecules in the inner ear using IV or oral administration. So the blood-brain...

...drug candidate SENS-401 View session detail Add to Schedule Author Block: *J. DYHRFJELD-JOHNSEN, M. PETREMANN, L. BEYNAC, A. BROUSSY; Sensorion SA, Montpellier, France Disclosure Block: J. Dyhrfjeld-Johnsen: None. M. Petremann: None. L. Beynac: None. A. Broussy: None. Support...

Have posted this before, so sorry to anyone that’s a bit annoyed by me posting this again… still wanted it to share it though. Not everything I've listed is based in the US but I'd say if, for example, a European company found the cure for hearing loss it would eventually also hit the US market...

...follow developments from the leading otology pharma companies - the ones that are publicly traded, that is (i.e. Auris Medical, Otonomy and Sensorion). But the path to market launch is not always easy when it comes to tinnitus related drugs and interventions. At the moment, I do not believe...

Thanks for this

...that should reduce treatment burden and improve efficacy over off-label steroids. At least two in this category, SENS-401 from Sensorion S.A. (Euronext:ALSEN) and AF243 from Affichem S.A., may also promote repair of axons and synapses. Compounds in the otoprotective category below protect...

This thread is no longer being updated. To see the most up to date list of companies, please go to the Cochlear Pro website. This is a list of biotech companies developing cures for inner ear damage and disorders (hearing and balance). With reservation for errors, such as name of the CEO or...

What if FDA pass new regulation for clinical trial. Can we expect novartis-genvec sooner?

Yes, we are at the beginning of 2016. It's likely that many research news will come this year. There won't be a cure next year or even in 5 years, it's much more in the future, but they get closer. It's not certain, that the protective approach or even a acute repair approach comes first. From...

...sharing the prize with Robert Fettiplace, university of Wisconsin-Madison, and Christine Petit who is on the scientific advisory board of Sensorion. (y) Here is a short summary of their work. "James Hudspeth has provided the major framework for our understanding of the process that...

I’d really recommend you to have a look at the research section and to use the search function. Devices Against Tinnitus Lenire by Neuromod is coming to the European Market in 2019, hopefully soon afterward to the US and other countries University of Michigan University of Minnesota

I dont expect a treatment at all, considering the zero progress in the last 50 years.

Recent developments Frequency Therapeutics - hearing loss regeneration completed phase 1 phase 1/2 to begin this year and phase 2 next year New device against tinnitus by the University of Michigan (Susan Shore) phase 2 expected to begin in autumn Xenon pharma expected to begin phase 2 by...

...much on the horizon for inner era treatment. If any of the molecules really dose it´s job we should have exiting news late 2015 or 2016. Sensorion is spun off from Inserm that just recently raised a total of €8.2 million. In other words well founded. Based in France. Their approach...